XXXXXXXXX XXXXXXXX XXXXXX (XX) 2023/543
xx dne 9.&xxxx;xxxxxx 2023,
kterým xx xxxx prováděcí nařízení (XX) x.&xxxx;686/2012, xxxxx xxx x&xxxx;xxxxxxxxx xxxxxxxxx xxxxxxxx xxxxx, jejichž xxxxxxxx xxxxxx x&xxxx;xxxxxx xx 31.&xxxx;xxxxx&xxxx;2029 xx 1.&xxxx;xxxxx&xxxx;2035, členským xxxxxx xxx účely xxxxxxx xxxxxxxx
(Xxxx s významem pro XXX)
XXXXXXXX XXXXXX,
x&xxxx;xxxxxxx xx Xxxxxxx x&xxxx;xxxxxxxxx Xxxxxxxx xxxx,
x&xxxx;xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Rady (XX) č. 1107/2009 xx xxx 21.&xxxx;xxxxx&xxxx;2009 x&xxxx;xxxxxxx xxxxxxxxx xx xxxxxxx xxxxxxx na trh x&xxxx;x&xxxx;xxxxxxx xxxxxxx Xxxx&xxxx;79/117/XXX x&xxxx;91/414/XXX&xxxx;(1), x&xxxx;xxxxxxx xx xxxxxx&xxxx;19 xxxxxxxxx nařízení,
vzhledem x&xxxx;xxxxx xxxxxxx:
|
(1) |
Xxxxxxxxx nařízení Xxxxxx (XX) x.&xxxx;686/2012&xxxx;(2) xxxxxxxxx xxxxxxxxx xxxxxxxx xxxxx xxx xxxxx xxxxxxx obnovení xxxxxxxxxxxxxx xxxxxxxxx xxxxx x&xxxx;xxxxxxxxxxxxxxxxxxx xxxxxxxxx xxxxx. Xxxxxxx xxxxxxxxx účinných látek, xxxxxxx xxxxxxxx xxxxxx x&xxxx;xxxxxx xx 31.&xxxx;xxxxx&xxxx;2029 xx 1.&xxxx;xxxxx&xxxx;2035, dosud xxxxxx xxxxxxxxxxxxxx nebo xxxxxxxxxxxxxxxxxxx xxxxxxxxx xxxxx xxxxxxxxx, je namístě xxxx přidělení xxxxxxx. |
|
(2) |
Xxxx xxxxxxxxx xx xxxx xxx xxxxxxxxx způsobem, xxxxx zajistí vyvážené xxxxxxxxx xxxxxxxxxx x&xxxx;xxxxxxxx xxxx xxxxxxxxx xxxxx. |
|
(3) |
Xxxxxxxxx xxxxxxxx (XX) x.&xxxx;686/2012 xx proto xxxx xxx odpovídajícím způsobem xxxxxxx. |
|
(4) |
Xxxxxxxx xxxxxxxxx xxxxx xxxxxxxxx xxxx x&xxxx;xxxxxxx xx stanoviskem Stálého xxxxxx xxx xxxxxxxx, xxxxxxx, xxxxxxxxx x&xxxx;xxxxxx, |
XXXXXXX XXXX XXXXXXXX:
Xxxxxx&xxxx;1
Xxxxxxxxx xxxxxxxx (XX) x.&xxxx;686/2012 xx xxxx x&xxxx;xxxxxxx s přílohou xxxxxx xxxxxxxx.
Článek 2
Toto nařízení vstupuje x&xxxx;xxxxxxxx dvacátým xxxx xx xxxxxxxxx x&xxxx;Xxxxxxx xxxxxxxx Xxxxxxxx xxxx.
Xxxx xxxxxxxx je xxxxxxx x&xxxx;xxxxx rozsahu x&xxxx;xxxxx použitelné xx xxxxx xxxxxxxxx xxxxxxx.
X&xxxx;Xxxxxxx xxx 9.&xxxx;xxxxxx 2023.
Za Xxxxxx
xxxxxxxxxxx
Xxxxxx XXX XXX XXXXX
(1)&xxxx;&xxxx;Xx.&xxxx;xxxx.&xxxx;X&xxxx;309, 24.11.2009, s. 1.
(2) Prováděcí xxxxxxxx Xxxxxx (XX) x.&xxxx;686/2012 xx xxx 26.&xxxx;xxxxxxxx&xxxx;2012, xxxxxx xx xxxxxxxxx hodnocení xxxxxxxx xxxxx členským xxxxxx xxx xxxxx postupu xxxxxxxx (Úř. věst. L 200, 27.7.2012, x.&xxxx;5).
XXXXXXX
X&xxxx;xxxxxxx xxxxxxxxxxx xxxxxxxx (XX) č. 686/2012 xx xxxxxxxx xxxx xxxx X, xxxxx zní:
„Část X
Xxxxxxxxx xxxxxxxxx účinných xxxxx, jejichž xxxxxxxx xxxxxx x&xxxx;xxxxxx od 31.&xxxx;xxxxx&xxxx;2029 xx 1. října 2035
|
Účinná xxxxx |
Xxxxxxxxxxxx xxxxxxx xxxx |
Xxxxxxxxxxxxxxxxx xxxxxxx xxxx |
|
1-xxxxxxxxxxxxxxxxx |
XX |
XX |
|
2,4-X |
XX |
XX |
|
2,4-XX |
XX |
XX |
|
XXX-XX 56 |
FR |
PT |
|
Acetamiprid |
DE |
ES |
|
Acibenzolar-S-methyl |
ES |
BE |
|
Ampelomyces xxxxxxxxxx xxxx XX10 |
XX |
XX |
|
Xxxxxxxx xxxxxxxxxxxxxxxxx xxxx XXX24 |
XX |
XX |
|
Xxxxxxxx xxxxxxxx xxxx&xxxx;XXX/XX03 |
XX |
XX |
|
Xxxxxxxxx xxxxxxxx xxxx 203 |
XX |
XX |
|
Xxxxxxxxx bassiana xxxx XXX389521 |
XX |
XX |
|
Xxxxxxxxx xxxxxxxx xxxx XXXX 5339 |
XX |
XX |
|
Xxxxxxxx xxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxxxxxxx |
XX |
XX |
|
Xxxxxx |
XX |
XX |
|
Xxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxx xxxxx xxxx X1446 |
XX |
XX |
|
Xxxxxxxxxxxx xxxxxxxx kmen CON/M/91-08 |
AT |
EE |
|
COS-OGA |
FR |
HR |
|
Cyhalofopbutyl |
CZ |
BE |
|
Cypermethrin |
CZ |
DE |
|
Dimethenamid-P |
BE |
DE |
|
Ethofumesát |
AT |
FI |
|
Fenhexamid |
BE |
CZ |
|
Fosforečnan xxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxxx xxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxxxx-xxxxxx |
XX |
XX |
|
Xxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxx |
XX |
XX |
|
Xxxxxx xxxxxxxxxxx xxxx Xxxxxx 97 |
XX |
XX |
|
Xxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxx-xxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxx |
XX |
XX |
|
Xxxxxxxxx-X |
XX |
XX |
|
Xxxxx xxxxxxx pepina xxxxx xxxxxx XX1 |
XX |
XX |
|
Xxxxx mozaiky xxxxxx xxxxx xxxxxx XX1 |
XX |
XX |
|
Xxxxxxxxx xxxxxxxxxx Xx1 |
XX |
XX |
|
Xxxxx xxxxxxx pepina xxxx XX2 xxxxxx 1906 |
XX |
XX |
|
Xxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxx xxxxxxxx kmen XXX XX 410.3 |
XX |
XX |
|
Xxxxxxxxxxx xxxxxxxx xxxx XXX 1835 |
XX |
XX |
|
Xxxxxxxxxxx xxxxxxxx xxxx VRA 1984 |
XX |
XX |
|
Xxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxx-xxxxx |
XX |
XX |
|
Xxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxxx xxxxxxxxxx xxxx XXX02 |
XX |
XX |
|
Xxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxxxxxxx xxxxx |
XX |
XX |
|
Xxxxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxxxx-xxxxxx |
XX |
XX |
|
Xxxxxxxxx-xxxxxx |
XX |
XX |
|
Xxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxx atroviride xxxx XX1 |
XX |
XX |
|
Xxxxxxxxxxxxxxx |
XX |
XX |
|
Xxxxxxxxxxxx albo-atrum xxxx XXX850 |
XX |
XX |
|
Xxxxxxx |
XX |
XX“ |